Boston Scientific Corp (BSX) stock
BSXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3047% below fair value
$43.03−0.66 (-1.51%)
Close on Nov 17, 2026Market cap $62.36BP/E 17.4Yield –
Boston Scientific price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Boston Scientific's price to book ratio was 2.7× on Nov 11, 2026, against 6.5× a year earlier. Over the last 5 years it ranged from 2.5× to 7.3×, with a median of 4.3×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.7× | −3.4 |
| 2025 | Dec 31, 2025 | 6.1× | −0.3 |
| 2024 | Dec 31, 2024 | 6.4× | +1.9 |
| 2023 | Dec 29, 2023 | 4.5× | +0.7 |
| 2022 | Dec 30, 2022 | 3.8× | – |
See a number that looks wrong?